Refine Search
(21)
(55)
(133)
(233)

Central Nervous System

GlobalData provides unique and market-leading data and insights into the central nervous system market. Browse or search our Report Store for the latest comprehensive reports, market data, analysis and survey findings alongside industry information on key companies, markets and financial deals.

Brain Hemorrhage Global Clinical Trials Review, H2, 2018

  • $2,500
  • December 2018
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Brain Hemorrhage Global Clinical Trials Review, H2, 2018" provides an overview of Brain Hemorrhage clinical trials scenario. This report provides top line data relating to the clinical trials on Bra...

Bulimia Nervosa Global Clinical Trials Review, H2, 2018

  • $2,500
  • December 2018
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Bulimia Nervosa Global Clinical Trials Review, H2, 2018" provides an overview of Bulimia Nervosa clinical trials scenario. This report provides top line data relating to the clinical trials on Bulim...

Cancer Pain Global Clinical Trials Review, H2, 2018

  • $2,500
  • December 2018
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Cancer Pain Global Clinical Trials Review, H2, 2018" provides an overview of Cancer Pain clinical trials scenario. This report provides top line data relating to the clinical trials on Cancer Pain. ...

Carpal Tunnel Syndrome Global Clinical Trials Review, H2, 2018

  • $2,500
  • December 2018
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Carpal Tunnel Syndrome Global Clinical Trials Review, H2, 2018" provides an overview of Carpal Tunnel Syndrome clinical trials scenario. This report provides top line data relating to the clinical t...

Cerebellar Ataxia Global Clinical Trials Review, H2, 2018

  • $2,500
  • December 2018
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Cerebellar Ataxia Global Clinical Trials Review, H2, 2018" provides an overview of Cerebellar Ataxia clinical trials scenario. This report provides top line data relating to the clinical trials on C...

Cerebral Palsy Global Clinical Trials Review, H2, 2018

  • $2,500
  • December 2018
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Cerebral Palsy Global Clinical Trials Review, H2, 2018" provides an overview of Cerebral Palsy clinical trials scenario. This report provides top line data relating to the clinical trials on Cerebra...

Chemotherapy Induced Pain Global Clinical Trials Review, H2, 2018

  • $2,500
  • December 2018
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Chemotherapy Induced Pain Global Clinical Trials Review, H2, 2018" provides an overview of Chemotherapy Induced Pain clinical trials scenario. This report provides top line data relating to the clin...

Childhood Epilepsy Global Clinical Trials Review, H2, 2018

  • $2,500
  • December 2018
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Childhood Epilepsy Global Clinical Trials Review, H2, 2018" provides an overview of Childhood Epilepsy clinical trials scenario. This report provides top line data relating to the clinical trials on...

Chorea Global Clinical Trials Review, H2, 2018

  • $2,500
  • December 2018
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Chorea Global Clinical Trials Review, H2, 2018" provides an overview of Chorea clinical trials scenario. This report provides top line data relating to the clinical trials on Chorea. Report includes...

Multiple Sclerosis: Dynamic Market Forecast to 2026

  • $8,495
  • November 2018
Add to Basket Quick View Add to Saved List

Multiple Sclerosis (MS) is a rapidly evolving field in which new developments are constantly influencing the market landscape.

The Dynamic Market Forecast is designed to help clients stay abreast of the latest news in the MS space, inclu...

Opioid Use Disorder: Opportunity Analysis and Forecasts to 2027

  • $10,995
  • November 2018
Add to Basket Quick View Add to Saved List

Opioid Use Disorder (OUD) is a chronic disorder that is described as the consequences associated with repeated, compulsive use of opioid drugs, and prolonged self-administration of opioid drugs. There are two subsets of patients that suffer fro...

Opioid Use Disorder: Epidemiology Forecast to 2027

  • $3,995
  • November 2018
Add to Basket Quick View Add to Saved List

Opioid use disorder (OUD) is defined in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) as a problematic pattern of opioid use leading to clinically significant impairment or distress. Symptoms of OUD include st...

Appetite (Eating) Disorders Global Clinical Trials Review, H2, 2018

  • $2,500
  • November 2018
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Appetite (Eating) Disorders Global Clinical Trials Review, H2, 2018" provides an overview of Appetite (Eating) Disorders clinical trials scenario. This report provides top line data relating to the ...

Asperger Syndrome Global Clinical Trials Review, H2, 2018

  • $2,500
  • November 2018
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Asperger Syndrome Global Clinical Trials Review, H2, 2018" provides an overview of Asperger Syndrome clinical trials scenario. This report provides top line data relating to the clinical trials on A...

Ataxia Global Clinical Trials Review, H2, 2018

  • $2,500
  • November 2018
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Ataxia Global Clinical Trials Review, H2, 2018" provides an overview of Ataxia clinical trials scenario. This report provides top line data relating to the clinical trials on Ataxia. Report includes...

Join our mailing list
Find out first about the latest reports and offers.